Details of the Drug

General Information of Drug (ID: DM10RQH)

Drug Name
CPC-201
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 2 [1]
Cross-matching ID
TTD ID
D0PN4D

References

1 ClinicalTrials.gov (NCT02185053) A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia. U.S. National Institutes of Health.